Pharma-Bio Serv Cash Flow Statement

Financials in millions USD. Fiscal year is November - October.

Millions USD. Fiscal year is Nov - Oct.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2005
Net Income	1.31	1.01	-2.09	2.05	2.09	1.28	-1.41	-0.26	1.62	2.41	Upgrade
Depreciation & Amortization	0.19	0.05	0.07	0.09	0.1	0.07	0.44	0.31	0.36	0.38	Upgrade
Share-Based Compensation	0.05	0.07	0.06	0.04	0.03	0.05	0.06	0.09	0.09	0.09	Upgrade
Other Operating Activities	0.34	-0.54	2.77	-0.65	-4.43	2.31	-0.64	0.56	-1.7	0.45	Upgrade
Operating Cash Flow	1.89	0.59	0.8	1.53	-2.21	3.72	-1.55	0.71	0.37	3.33	Upgrade
Operating Cash Flow Growth	219.17%	-26.39%	-47.24%	-	-	-	-	90.46%	-88.81%	-40.81%	Upgrade
Capital Expenditures	-0.01	-0.02	-0.01	-0.06	-0.06	-0.12	-0.45	-1.81	-0.34	-0.21	Upgrade
Acquisitions	0	0	0.06	0.03	0.1	0	0	0	0	0	Upgrade
Change in Investments	-4.21	-	-	-	-0.14	-	-	-	-	-	Upgrade
Other Investing Activities	-	-	1.25	-	1.94	0.01	0.05	0.03	-	0.04	Upgrade
Investing Cash Flow	-4.22	-0.02	1.3	-0.03	1.84	-0.12	-0.4	-1.78	-0.34	-0.17	Upgrade
Dividends Paid	-1.72	-3.45	-1.73	-1.73	0	-1.73	0	0	0	-73.18	Upgrade
Common Stock Issued	0	0	0	0	0	0	0	0	0	30	Upgrade
Share Repurchases	-0.03	-0.08	-0.03	-0	-0.09	-0.06	-0.02	-0.05	-0.17	-0.02	Upgrade
Other Financing Activities	-0.07	-0.16	-0.05	1.92	-0.24	-0.13	-0.09	-0.11	-0.36	43.07	Upgrade
Financing Cash Flow	-1.76	-3.53	-1.75	0.19	-0.16	-1.8	-0.07	-0.07	-0.19	-0.09	Upgrade
Net Cash Flow	-4.02	-3.01	0.33	1.65	-0.54	4.44	-2.02	-1.12	-0.19	3.04	Upgrade
Free Cash Flow	1.88	0.57	0.79	1.47	-2.27	3.6	-2	-1.1	0.03	3.12	Upgrade
Free Cash Flow Growth	228.64%	-27.81%	-45.98%	-	-	-	-	-	-99.03%	-42.24%	Upgrade
Free Cash Flow Margin	11.10%	2.95%	3.95%	6.82%	-11.61%	20.21%	-12.84%	-5.63%	0.13%	11.33%	Upgrade
Free Cash Flow Per Share	0.08	0.02	0.03	0.06	-0.10	0.16	-0.09	-0.05	0.00	0.13	Upgrade

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.